发明人周伟,徐明华,刘建华. "一种克唑替尼杂质69的合成方法" [P]. 中国发明专利, 专利号 CN 109954344 A, 授权公告日 2019-01-03.
Nowak P, Nielsen H, Kowalski A. "Method for the Synthesis of Crizotinib Impurity 69" [P]. European Patent, EP 3644986 A1, 2016-07-11.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质69 in Pharmaceutical Formulations". Anal. Methods, 2021, 1745, 1171-1195.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质69 as an Impurity". J. Chromatogr. A, 2020, 2335, (12), 3672-3685.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib Impurity 69 Using HRMS and NMR". J. Nat. Prod., 2015, 1656, 6689-6714.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 克唑替尼杂质69 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2020, 1681, (5), 4436-4442.